Cargando…
Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
Pancreatic cancer (PC) is a malignant tumor with high malignancy that is difficult to diagnose and treat. PC is a major medical problem because of its low early diagnosis rate, high surgical mortality rate, low cure rate, and expensive related testing cost. Therefore, the significance of finding new...
Autores principales: | Liu, Dahai, Li, Jie, Qi, Fei, You, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880980/ https://www.ncbi.nlm.nih.gov/pubmed/36713527 http://dx.doi.org/10.3389/fonc.2022.1106762 |
Ejemplares similares
-
Semaphorins and Their Receptors in Hematological Malignancies
por: Wei, Li, et al.
Publicado: (2019) -
Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022) -
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer
por: Mastrantonio, Roberta, et al.
Publicado: (2021) -
Semaphorin 3F induces colorectal cancer cell chemosensitivity by promoting P27 nuclear export
por: Tao, Miaomiao, et al.
Publicado: (2022) -
Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities
por: Tabnak, Peyman, et al.
Publicado: (2021)